Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.
Lother SA, Teng W, Ayilara O, Houston BL, Rush B, Murthy S, Nicolau JC, Bond L, Turgeon AF, Marshall JC, Paul J, Hochman JS, Neal MD, Farkouh ME, Nkosi J, Houston DS, Bradbury CA, Mendelson AA, Goligher EC, Garland A, Balshaw R, Shaw SY, Lawler PR, Keynan Y, Zarychanski R.
Lother SA, et al. Among authors: teng w.
Res Pract Thromb Haemost. 2025 May 21;9(4):102893. doi: 10.1016/j.rpth.2025.102893. eCollection 2025 May.
Res Pract Thromb Haemost. 2025.
PMID: 40613068
Free PMC article.